BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 19020042)

  • 1. Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
    Karunakaran S; Saeed U; Mishra M; Valli RK; Joshi SD; Meka DP; Seth P; Ravindranath V
    J Neurosci; 2008 Nov; 28(47):12500-9. PubMed ID: 19020042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF-kappaB in MPTP-treated mice: implication in Parkinson's disease.
    Karunakaran S; Ravindranath V
    J Neurochem; 2009 Jun; 109(6):1791-9. PubMed ID: 19457134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid.
    Karunakaran S; Diwakar L; Saeed U; Agarwal V; Ramakrishnan S; Iyengar S; Ravindranath V
    FASEB J; 2007 Jul; 21(9):2226-36. PubMed ID: 17369508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p38(MAPK)/p53-Mediated Bax induction contributes to neurons degeneration in rotenone-induced cellular and rat models of Parkinson's disease.
    Wu F; Wang Z; Gu JH; Ge JB; Liang ZQ; Qin ZH
    Neurochem Int; 2013 Sep; 63(3):133-40. PubMed ID: 23714208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS; Brown EM; Miller MS; Carswell S
    J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione S-transferase pi mediates MPTP-induced c-Jun N-terminal kinase activation in the nigrostriatal pathway.
    Castro-Caldas M; Carvalho AN; Rodrigues E; Henderson C; Wolf CR; Gama MJ
    Mol Neurobiol; 2012 Jun; 45(3):466-77. PubMed ID: 22539231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
    Pariyar R; Bastola T; Lee DH; Seo J
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JNK-mediated activation of ATF2 contributes to dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease.
    Huang Q; Du X; He X; Yu Q; Hu K; Breitwieser W; Shen Q; Ma S; Li M
    Exp Neurol; 2016 Mar; 277():296-304. PubMed ID: 26515688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease.
    Wang Y; Zhang Y; Wei Z; Li H; Zhou H; Zhang Z; Zhang Z
    J Neurol Sci; 2009 Oct; 285(1-2):172-7. PubMed ID: 19604516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation.
    Moon M; Kim HG; Hwang L; Seo JH; Kim S; Hwang S; Kim S; Lee D; Chung H; Oh MS; Lee KT; Park S
    Neurotox Res; 2009 May; 15(4):332-47. PubMed ID: 19384567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
    Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
    Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra.
    Jiang H; Li LJ; Wang J; Xie JX
    Exp Neurol; 2008 Aug; 212(2):532-7. PubMed ID: 18577498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice.
    Ding YX; Xia Y; Jiao XY; Duan L; Yu J; Wang X; Chen LW
    Neurochem Res; 2011 Oct; 36(10):1759-66. PubMed ID: 21562748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iptakalim protects against MPP+-induced degeneration of dopaminergic neurons in association with astrocyte activation.
    Yang YJ; Zhang S; Ding JH; Zhou F; Hu G
    Int J Neuropsychopharmacol; 2009 Apr; 12(3):317-27. PubMed ID: 18700057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease.
    Xia XG; Harding T; Weller M; Bieneman A; Uney JB; Schulz JB
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10433-8. PubMed ID: 11504916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MPTP activates ASK1-p38 MAPK signaling pathway through TNF-dependent Trx1 oxidation in parkinsonism mouse model.
    Ray A; Sehgal N; Karunakaran S; Rangarajan G; Ravindranath V
    Free Radic Biol Med; 2015 Oct; 87():312-25. PubMed ID: 26164633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Zishenpingchan granule prepared from Chinese medicinal substances on the c-Jun N-terminal protein kinase pathway in mice with Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Ye Q; Yuan X; Zhou J; Yuan C; Yang X
    J Tradit Chin Med; 2017 Apr; 37(2):244-51. PubMed ID: 29960635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo.
    Saporito MS; Thomas BA; Scott RW
    J Neurochem; 2000 Sep; 75(3):1200-8. PubMed ID: 10936203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
    Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS
    Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.